Search results
Results from the WOW.Com Content Network
Arachidonate 5-lipoxygenase inhibitors are compounds that slow or stop the action of the arachidonate 5-lipoxygenase (5-lipoxygenase or 5-LOX) enzyme, which is responsible for the production of inflammatory leukotrienes. The overproduction of leukotrienes is a major cause of inflammation in asthma, allergic rhinitis, and osteoarthritis. [1] [2]
This is referred to as air inhibition and is a diffusion-controlled reaction with rates typically in the order of 10 7 –10 9 mol −1 s −1, [3] the resulting peroxy radicals (ROO•) are less reactive towards polymerisation. However air stabilisation is not suitable for monomers with which it can form explosive peroxides, such as vinyl ...
A specialist may request a quantitative factor Xa assay in a situation of overdose. [2] Andexanet alfa, a specific antidote to reverse the anticoagulant activity of direct Xa inhibitors in the event of major bleeding, was approved by the FDA in 2018. [9] It is also available in the UK. [10]
Bottom: by binding to the enzyme, inhibitor (I) blocks binding of substrate. Binding site shown in blue checkerboard, substrate as black rectangle, and inhibitor as green rounded rectangle. An enzyme inhibitor is a molecule that binds to an enzyme and blocks its activity.
Topoisomerase inhibitors (2 C, 38 P) Transferase inhibitors (13 C, 6 P) Pages in category "Enzyme inhibitors" The following 90 pages are in this category, out of 90 ...
AM-679 is a drug which acts as a selective inhibitor of 5-Lipoxygenase-activating protein (FLAP). This protein is involved in the production of cysteinyl leukotrienes which are involved in inflammation, and AM-679 has anti-inflammatory effects in animal studies. [1] [2]
These phosphinate MMP inhibitors contain phenyl segments that are thought to be responsible for the selectivity to MMP-13. The phosphinic group of those inhibitors (R 1 R 2 (O)OH) binds as a zinc ligand. R 1 and R 2 substituents affect the inhibition potency. [7] Phosphinate inhibitors have been developed that showed high selectivity for MMP-11.
Dapagliflozin is an example of an SGLT-2 inhibitor, it is a competitive, highly selective inhibitor of SGLT. It acts via selective and potent inhibition of SGLT-2, and its activity is based on each patient's underlying blood sugar control and kidney function. The results are decreased kidney reabsorption of glucose, glucosuria effect increases ...